|
US3740412A
(en)
*
|
1970-04-08 |
1973-06-19 |
Synvar Ass |
Imidazoline-3-oxide-1-oxyl derivatives
|
|
US3997223A
(en)
*
|
1975-04-30 |
1976-12-14 |
Dynascan Corporation |
Apparatus and method for rejuvenating cathode ray tubes
|
|
US4166452A
(en)
*
|
1976-05-03 |
1979-09-04 |
Generales Constantine D J Jr |
Apparatus for testing human responses to stimuli
|
|
US4256108A
(en)
*
|
1977-04-07 |
1981-03-17 |
Alza Corporation |
Microporous-semipermeable laminated osmotic system
|
|
US4267333A
(en)
*
|
1979-09-26 |
1981-05-12 |
Union Carbide Agricultural Products Company, Inc. |
Preparation of 2-trifluoromethyl cinchoninic acids
|
|
US4265874A
(en)
*
|
1980-04-25 |
1981-05-05 |
Alza Corporation |
Method of delivering drug with aid of effervescent activity generated in environment of use
|
|
US4435419A
(en)
*
|
1981-07-01 |
1984-03-06 |
American Cyanamid Company |
Method of treating depression using azabicyclohexanes
|
|
US4431661A
(en)
*
|
1981-08-20 |
1984-02-14 |
American Cyanamid Company |
5-Aryl-3-azabicyclo[3.2.0]heptan-6-one acetals, and analgesic use therefor
|
|
AU534404B2
(en)
*
|
1981-09-01 |
1984-01-26 |
American Cyanamid Company |
Cyclopropane derivatives
|
|
US4490055A
(en)
|
1982-06-30 |
1984-12-25 |
International Business Machines Corporation |
Automatically adjustable delay function for timed typamatic
|
|
US4544665A
(en)
*
|
1983-11-21 |
1985-10-01 |
American Cyanamid Company |
1-Aryl-3-azabicyclo[3.2.0]heptanes
|
|
GB2200628A
(en)
*
|
1987-02-06 |
1988-08-10 |
Shell Int Research |
Diphenyl ether herbicides
|
|
US5089633A
(en)
*
|
1987-04-28 |
1992-02-18 |
Georgia Tech Research Corporation |
Substituted isocoumarins
|
|
GB8827305D0
(en)
|
1988-11-23 |
1988-12-29 |
British Bio Technology |
Compounds
|
|
JPH032797A
(ja)
|
1989-05-30 |
1991-01-09 |
Meidensha Corp |
音声合成装置の抑揚制御方式
|
|
US5037853A
(en)
*
|
1989-12-28 |
1991-08-06 |
Abbott Laboratories |
Cyclopropyl derivative lipoxygenase inhibitors
|
|
US5120752A
(en)
*
|
1989-12-28 |
1992-06-09 |
Abbott Laboratories |
Cyclopropyl derivative lipoxygenase inhibitors
|
|
US5114953A
(en)
*
|
1990-11-21 |
1992-05-19 |
University Of Florida |
Treatment for tissue ulceration
|
|
GB9102635D0
(en)
|
1991-02-07 |
1991-03-27 |
British Bio Technology |
Compounds
|
|
US5256657A
(en)
*
|
1991-08-19 |
1993-10-26 |
Sterling Winthrop, Inc. |
Succinamide derivative matrix-metalloprotease inhibitors
|
|
WO1993007111A1
(en)
|
1991-10-02 |
1993-04-15 |
Smithkline Beecham Corporation |
Cyclopentane and cyclopentene derivatives with antiallergic antiinflammatory and tumor necrosis factor inhibiting activity
|
|
JPH05262698A
(ja)
*
|
1992-03-24 |
1993-10-12 |
Dainippon Ink & Chem Inc |
光学活性トリフルオロメチルシクロプロパン誘導体、その合成中間体、それを含む液晶組成物及び液晶表示素子
|
|
EP0634998B1
(en)
|
1992-04-07 |
1997-03-19 |
British Biotech Pharmaceuticals Limited |
Hydroxamic acid based collagenase and cytokine inhibitors
|
|
US5674901A
(en)
*
|
1995-06-01 |
1997-10-07 |
Wisconsin Alumni Research Foundation |
Methods of treating animals to maintain or increase CD-4 and CD-8 cell populations
|
|
US5318964A
(en)
|
1992-06-11 |
1994-06-07 |
Hoffmann-La Roche Inc. |
Hydroxamic derivatives and pharmaceutical compositions
|
|
EP0648225A1
(en)
|
1992-06-25 |
1995-04-19 |
Chiron Corporation |
Compositions for the inhibition of protein hormone formation and uses thereof
|
|
GB9215665D0
(en)
|
1992-07-23 |
1992-09-09 |
British Bio Technology |
Compounds
|
|
GB9223904D0
(en)
|
1992-11-13 |
1993-01-06 |
British Bio Technology |
Inhibition of cytokine production
|
|
US5455258A
(en)
*
|
1993-01-06 |
1995-10-03 |
Ciba-Geigy Corporation |
Arylsulfonamido-substituted hydroxamic acids
|
|
US5552419A
(en)
*
|
1993-01-06 |
1996-09-03 |
Ciba-Geigy Corporation |
Arylsulfonamido-substituted hydroxamic acids
|
|
US5646167A
(en)
*
|
1993-01-06 |
1997-07-08 |
Ciba-Geigy Corporation |
Arylsulfonamido-substituted hydroxamix acids
|
|
US5506242A
(en)
*
|
1993-01-06 |
1996-04-09 |
Ciba-Geigy Corporation |
Arylsufonamido-substituted hydroxamic acids
|
|
AU672888B2
(en)
|
1993-03-18 |
1996-10-17 |
Otsuka Pharmaceutical Co., Ltd. |
Carbostyril derivatives as matrix metalloproteinases inhibitors
|
|
GB9307956D0
(en)
|
1993-04-17 |
1993-06-02 |
Walls Alan J |
Hydroxamic acid derivatives
|
|
JPH072797A
(ja)
|
1993-04-19 |
1995-01-06 |
Sankyo Co Ltd |
コラゲナーゼ阻害剤
|
|
GB9311282D0
(en)
*
|
1993-06-01 |
1993-07-21 |
Rhone Poulenc Rorer Ltd |
New compositions of matter
|
|
US5594106A
(en)
*
|
1993-08-23 |
1997-01-14 |
Immunex Corporation |
Inhibitors of TNF-α secretion
|
|
FI960803L
(fi)
|
1993-08-23 |
1996-04-22 |
Immunex Corp |
TNF-alfa-sekreetion inhibiittoreita
|
|
GB9320660D0
(en)
|
1993-10-07 |
1993-11-24 |
British Bio Technology |
Inhibition of cytokine production
|
|
DK0740652T3
(da)
|
1994-01-20 |
1999-02-01 |
British Biotech Pharm |
Metalloproteinaseinhibitorer
|
|
GB9401129D0
(en)
|
1994-01-21 |
1994-03-16 |
British Bio Technology |
Hydroxamic acid derivatives as metalloproteinase inhibitors
|
|
EP0740655B1
(en)
|
1994-01-22 |
1999-10-20 |
British Biotech Pharmaceuticals Limited |
Metalloproteinase inhibitors
|
|
US5514716A
(en)
*
|
1994-02-25 |
1996-05-07 |
Sterling Winthrop, Inc. |
Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof
|
|
CA2185162A1
(en)
|
1994-03-07 |
1995-09-14 |
Robert F. Halenback (Deceased) |
Compositions for the inhibition of tnf formation and uses thereof
|
|
GB9501737D0
(en)
|
1994-04-25 |
1995-03-22 |
Hoffmann La Roche |
Hydroxamic acid derivatives
|
|
AU2394795A
(en)
|
1994-04-28 |
1995-11-29 |
Du Pont Merck Pharmaceutical Company, The |
Hydroxamic acid and amino acid derivatives and their use as anti-arthritic agents
|
|
US5817822A
(en)
*
|
1994-06-24 |
1998-10-06 |
Novartis Corporation |
Certain alpha-azacycloalkyl substituted arylsulfonamido acetohydroxamic acids
|
|
US5840698A
(en)
|
1994-10-27 |
1998-11-24 |
Affymax Technologies N.V. |
Inhibitors of collagenase-1 and stormelysin-I metalloproteases, pharmaceutical compositions comprising same and methods of their use
|
|
JP2902318B2
(ja)
|
1994-12-28 |
1999-06-07 |
呉羽化学工業株式会社 |
エスクレチン誘導体、その製造方法及びマトリックスメタロプロテアーゼ阻害剤
|
|
US5703092A
(en)
|
1995-04-18 |
1997-12-30 |
The Dupont Merck Pharmaceutical Company |
Hydroxamic acid compounds as metalloprotease and TNF inhibitors
|
|
US5691381A
(en)
|
1995-04-18 |
1997-11-25 |
The Dupont Merck Pharmaceutical Company |
Hydroxamic and carbocyclic acids as metalloprotease inhibitors
|
|
US5880141A
(en)
|
1995-06-07 |
1999-03-09 |
Sugen, Inc. |
Benzylidene-Z-indoline compounds for the treatment of disease
|
|
GB2303130A
(en)
|
1995-07-10 |
1997-02-12 |
Secr Defence |
Cyclic oligomers of substituted cyclic ethers
|
|
GB9514867D0
(en)
*
|
1995-07-20 |
1995-09-20 |
British Biotech Pharm |
Metalloproteinase inhibitors
|
|
KR980009238A
(ko)
|
1995-07-28 |
1998-04-30 |
우에노 도시오 |
설포닐아미노산 유도체
|
|
WO1997009066A1
(en)
|
1995-09-08 |
1997-03-13 |
Kanebo, Ltd. |
Fas LIGAND SOLUBILIZATION INHIBITOR
|
|
HUP0003760A3
(en)
|
1995-10-05 |
2001-05-28 |
Darwin Discovery Ltd Cambridge |
Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation, process for production thereof and their use
|
|
US5665777A
(en)
|
1995-11-14 |
1997-09-09 |
Abbott Laboratories |
Biphenyl hydroxamate inhibitors of matrix metalloproteinases
|
|
CA2237524A1
(en)
|
1995-11-14 |
1997-05-22 |
Du Pont Pharmaceuticals Company |
Novel macrocyclic compounds as metalloprotease inhibitors
|
|
AU711804B2
(en)
|
1995-11-23 |
1999-10-21 |
British Biotech Pharmaceuticals Limited |
Metalloproteinase inhibitors
|
|
US5753653A
(en)
*
|
1995-12-08 |
1998-05-19 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
|
|
IL138027A
(en)
*
|
1995-12-08 |
2004-08-31 |
Agouron Pharma |
Intermediates for the preparation and preparation of metalloproteinase inhibitors
|
|
TW453995B
(en)
*
|
1995-12-15 |
2001-09-11 |
Novartis Ag |
Certain alpha-substituted arylsulfonamido acetohydroxamic acids
|
|
DE69624081T2
(de)
|
1995-12-20 |
2003-06-12 |
Agouron Pharmaceuticals, Inc. |
Matrix-metalloprotease Inhibitoren
|
|
PT871439E
(pt)
|
1996-01-02 |
2004-08-31 |
Aventis Pharma Inc |
Compostos do acido hidroxamico substituidos (arilo heteroarilo arilmetilo ou heteroarilmetilo)
|
|
JPH09202774A
(ja)
*
|
1996-01-25 |
1997-08-05 |
Green Cross Corp:The |
２−アリールキノリン類およびその製造方法
|
|
TW448172B
(en)
|
1996-03-08 |
2001-08-01 |
Pharmacia & Upjohn Co Llc |
Novel hydroxamic acid derivatives useful for the treatment of diseases related to connective tissue degradation
|
|
PT900211E
(pt)
|
1996-04-23 |
2003-10-31 |
Upjohn Co |
Tiadiazolil(tio)ureias uteis como inibidores de metaloproteases com matriz
|
|
WO1997042168A1
(en)
|
1996-05-06 |
1997-11-13 |
Zeneca Limited |
Thio derivatives of hydroxamic acids
|
|
IT1283637B1
(it)
*
|
1996-05-14 |
1998-04-23 |
Italfarmaco Spa |
Composti ad attivita' antinfiammatoria ed immunosoppressiva
|
|
WO1998002557A2
(en)
|
1996-07-12 |
1998-01-22 |
Schering Corporation |
MAMMALIAN TNF-α CONVERTASES
|
|
EP0818442A3
(en)
|
1996-07-12 |
1998-12-30 |
Pfizer Inc. |
Cyclic sulphone derivatives as inhibitors of metalloproteinases and of the production of tumour necrosis factor
|
|
US5853977A
(en)
*
|
1996-07-12 |
1998-12-29 |
Schering Corporation |
Mammalian TNF-α convertases
|
|
YU1899A
(sh)
|
1996-07-18 |
2000-03-21 |
Pfizer Inc. |
Inhibitori matričnih metaloproteaza na bazi fosfinata
|
|
WO1998003164A1
(en)
|
1996-07-22 |
1998-01-29 |
Monsanto Company |
Thiol sulfone metalloprotease inhibitors
|
|
EA199900139A1
(ru)
|
1996-08-23 |
1999-08-26 |
Пфайзер, Инк. |
Производные арилсульфониламиногидроксамовой кислоты
|
|
NZ334254A
(en)
|
1996-08-28 |
2000-11-24 |
Procter & Gamble |
Heterocyclic metalloprotease inhibitors
|
|
RU2170232C2
(ru)
*
|
1996-08-28 |
2001-07-10 |
Дзе Проктер Энд Гэмбл Компани |
Амиды фосфиновых кислот и способ предупреждения или лечения заболевания, связанного с нежелательной активностью металлопротеазы
|
|
DK0927168T3
(da)
|
1996-08-28 |
2003-03-10 |
Procter & Gamble |
1,3-diheterocykliske metalloproteaseinhibitorer
|
|
SK25199A3
(en)
|
1996-08-28 |
2000-02-14 |
Procter & Gamble |
Heterocyclic metalloprotease inhibitors
|
|
EP0929542A1
(en)
|
1996-09-04 |
1999-07-21 |
Warner-Lambert Company |
Compounds for and a method of inhibiting matrix metalloproteinases
|
|
KR100338610B1
(ko)
|
1996-09-04 |
2002-05-27 |
디. 제이. 우드, 스피겔 알렌 제이 |
인다졸 유도체 및 포스포디에스터라제 (pde) 유형 iv 및 종양괴사인자 (tnf) 생산의 억제제로서 그의 용도
|
|
PT928291E
(pt)
|
1996-09-19 |
2003-03-31 |
Aventis Pharma Inc |
Derivados de 3-mercaptoacetilamino-1,5-substituido-2-oxo-azepano uteis como inibidores de metaloproteinases matriciais
|
|
NZ334729A
(en)
|
1996-09-27 |
2001-01-26 |
Upjohn Co |
'Beta'-sulfonyl hydroxamic acids as matrix metalloproteinase inhibitors involved in tissue degradation
|
|
WO1998015525A1
(en)
|
1996-10-07 |
1998-04-16 |
Sumitomo Pharmaceuticals Co., Ltd. |
Hydroxamic acids
|
|
WO1998016520A1
(en)
|
1996-10-16 |
1998-04-23 |
American Cyanamid Company |
The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
|
|
NZ335028A
(en)
|
1996-10-16 |
2000-09-29 |
American Cyanamid Co |
Ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase (MMP) and TACE (TNF-alpha converting enzyme) inhibitors
|
|
KR20000049198A
(ko)
|
1996-10-16 |
2000-07-25 |
윌리암 에이취 캘넌, 에곤 이 버그 |
매트릭스 메탈로프로티나아제 및 ｔａｃｅ 억제제로서의 베타-설폰아미도 하이드록스암산
|
|
US5962481A
(en)
*
|
1996-10-16 |
1999-10-05 |
American Cyanamid Company |
Preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
|
|
AU743901B2
(en)
|
1996-10-16 |
2002-02-07 |
Wyeth Holdings Corporation |
Ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloprote inase and tace inhibitors
|
|
US6548524B2
(en)
*
|
1996-10-16 |
2003-04-15 |
American Cyanamid Company |
Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors
|
|
US5977408A
(en)
*
|
1996-10-16 |
1999-11-02 |
American Cyanamid Company |
Preparation and use of β-sulfonamido hydroxamic acids as matrix metalloproteinase and TACE inhibitors
|
|
GB9621814D0
(en)
|
1996-10-19 |
1996-12-11 |
British Biotech Pharm |
Metalloproteinase inhibitors
|
|
US6008243A
(en)
|
1996-10-24 |
1999-12-28 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use
|
|
MY117687A
(en)
|
1996-10-31 |
2004-07-31 |
Bayer Corp |
Substituted 4-biphenyl-4-hydroxybutric acid derivatives as matrix metalloprotease inhibitors
|
|
JPH10130217A
(ja)
|
1996-11-01 |
1998-05-19 |
Kotobuki Seiyaku Kk |
カルボン酸及びその誘導体及びその製造法並びにこれを含有する医薬組成物
|
|
GB9624817D0
(en)
|
1996-11-28 |
1997-01-15 |
British Biotech Pharm |
Metalloproteinase inhibitors
|
|
US5840974A
(en)
|
1996-12-04 |
1998-11-24 |
Britisch Biotech Pharmaceuticals, Ltd. |
Metalloproteinase inhibitors
|
|
EP0948489A1
(en)
|
1996-12-17 |
1999-10-13 |
Fujisawa Pharmaceutical Co., Ltd. |
Piperazine compounds as inhibitors of mmp or tnf
|
|
AU5131998A
(en)
|
1997-01-06 |
1998-08-03 |
Pfizer Inc. |
Cyclic sulfone derivatives
|
|
ZA9820B
(en)
|
1997-01-07 |
1998-07-02 |
Abbott Lab |
Macrocyclic inhibitors of matrix metalloproteinases and tnf x secretion
|
|
ZA9818B
(en)
|
1997-01-07 |
1998-07-02 |
Abbott Lab |
C-terminal ketone inhibitors of matrix metalloproteinases and tnf alpha secretion
|
|
US5837696A
(en)
*
|
1997-01-15 |
1998-11-17 |
The Research Foundation Of State University Of New York |
Method of inhibiting cancer growth
|
|
JPH10204054A
(ja)
|
1997-01-21 |
1998-08-04 |
Ono Pharmaceut Co Ltd |
フェニルスルホンアミド誘導体
|
|
JPH10204059A
(ja)
|
1997-01-22 |
1998-08-04 |
Ono Pharmaceut Co Ltd |
フェニルスルホンアミド誘導体
|
|
WO1998032748A1
(en)
|
1997-01-23 |
1998-07-30 |
F. Hoffmann-La Roche Ag |
Sulfamide-metalloprotease inhibitors
|
|
GB9702088D0
(en)
|
1997-01-31 |
1997-03-19 |
Pharmacia & Upjohn Spa |
Matrix metalloproteinase inhibitors
|
|
ZA981532B
(en)
|
1997-02-26 |
1999-08-24 |
Glaxo Group Ltd |
Reverse hydroxamate derivatives as matrix metalloprotease inhibitors, metalloprotease inhibitors, and TNF alpha inhibitors.
|
|
YU41399A
(sh)
|
1997-02-26 |
2001-09-28 |
Pfizer Inc. |
Derivati amida heteroaril-kapronske kiseline, njihovo dobijanje i njihova upotreba kao selektivnih inhibitora mip-1.alfa vezivanjem za njegov ccr1 receptor
|
|
EE04295B1
(et)
|
1997-02-27 |
2004-06-15 |
American Cyanamid Company |
N-hüdroksü-2-(alküül-, arüül- või heteroarüülsulfanüül-, -sulfinüül- või-sulfonüül-)-3-asendatud-alküülamiidid, -arüülamiidid või -heteroarüülamiididkui maatriksmetalloproteinaasi inhibiitorid
|
|
US6172057B1
(en)
*
|
1997-02-27 |
2001-01-09 |
American Cyanamid Company |
N-Hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
|
|
US6197791B1
(en)
*
|
1997-02-27 |
2001-03-06 |
American Cyanamid Company |
N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
|
|
JP2001500899A
(ja)
|
1997-03-11 |
2001-01-23 |
レ ラボラトワール エテルナ インコーポレイティド |
高い効能及び少ない副作用を供与する軟骨エキスと抗新形成剤との組合せを含んで成る抗腫瘍療法
|
|
US6034136A
(en)
|
1997-03-20 |
2000-03-07 |
Novartis Ag |
Certain cyclic thio substituted acylaminoacid amide derivatives
|
|
AU6843298A
(en)
|
1997-03-28 |
1998-10-22 |
Zeneca Limited |
Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor
|
|
NZ338082A
(en)
|
1997-04-01 |
2000-06-23 |
Agouron Pharma |
Metalloproteinase and Tumor Necrosis Factor-alpha convertase inhibitors, pharmaceutical compositions and their use in treating disease mediated by metalloproteinase activity.
|
|
US5985900A
(en)
*
|
1997-04-01 |
1999-11-16 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
|
|
AT404904B
(de)
|
1997-04-03 |
1999-03-25 |
Prior Eng Ag |
Vorrichtung zur kontinuierlichen annularen chromatographie
|
|
GB9707333D0
(en)
|
1997-04-11 |
1997-05-28 |
British Biotech Pharm |
Metalloproteinase inhibitors
|
|
AU7294098A
(en)
|
1997-05-09 |
1998-11-27 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
|
|
EP0877019B1
(de)
|
1997-05-09 |
2001-12-12 |
Hoechst Aktiengesellschaft |
Substituierte Diaminocarbonsäuren
|
|
DE19719621A1
(de)
|
1997-05-09 |
1998-11-12 |
Hoechst Ag |
Sulfonylaminocarbonsäuren
|
|
US5804581A
(en)
*
|
1997-05-15 |
1998-09-08 |
Bayer Corporation |
Inhibition of matrix metalloproteases by substituted phenalkyl compounds
|
|
GB9710490D0
(en)
|
1997-05-21 |
1997-07-16 |
British Biotech Pharm |
Metalloproteinase inhibitors
|
|
EP0887077A1
(de)
|
1997-06-27 |
1998-12-30 |
Roche Diagnostics GmbH |
Verwendung von Azulenderivaten als Metalloproteaseinhibitoren
|
|
JP2001500533A
(ja)
|
1997-07-10 |
2001-01-16 |
フアルマシア・エ・アツプジヨン・エツセ・ピー・アー |
マトリックスメタロプロテイナーゼ・インヒビター
|
|
EP1003751A1
(en)
|
1997-08-04 |
2000-05-31 |
Amgen Inc. |
Hydroxamic acid substituted fused heterocyclic metalloproteinase inhibitors
|
|
DK0895988T3
(da)
|
1997-08-08 |
2002-09-09 |
Pfizer Prod Inc |
Arylsulfonylaminohydroxamsyrederivater
|
|
ZA988967B
(en)
|
1997-10-03 |
2000-04-03 |
Du Pont Pharm Co |
Lactam metalloprotease inhibitors.
|
|
JP2003520183A
(ja)
|
1997-10-06 |
2003-07-02 |
アメリカン・サイアナミド・カンパニー |
マトリクス金属プロテイナーゼおよびｔａｃｅ阻害薬としてのオルト−スルホンアミド二環式ヘテロアリールヒドロキサム酸の製造および使用
|
|
AU9663798A
(en)
|
1997-10-06 |
1999-04-27 |
Warner-Lambert Company |
Heteroaryl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
|
|
CN1282319A
(zh)
|
1997-10-09 |
2001-01-31 |
小野药品工业株式会社 |
氨基丁酸衍生物
|
|
DE69829875T2
(de)
*
|
1997-10-14 |
2006-03-09 |
Mitsubishi Pharma Corp. |
Piperazin-verbindungen und ihre medizinische verwendung
|
|
GB9723905D0
(en)
|
1997-11-12 |
1998-01-07 |
Chiroscience Ltd |
Heterocyclic compounds having MMP and TNF inhibitory activity
|
|
DK1030836T3
(da)
|
1997-11-12 |
2003-05-26 |
Darwin Discovery Ltd |
Hydroxam- og carboxylsyrederivater der har MMP- og TNF-inhiberende aktivitet
|
|
DE69828638T2
(de)
|
1997-11-12 |
2005-12-01 |
Darwin Discovery Ltd., Slough |
Hydroxam- und carbonsäurederivate mit mmp- und tnf-hemmender aktivität
|
|
WO1999025693A1
(en)
|
1997-11-13 |
1999-05-27 |
British Biotech Pharmaceuticals Limited |
Metalloproteinase inhibitors
|
|
FR2771095B1
(fr)
*
|
1997-11-14 |
1999-12-17 |
Adir |
Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
CN1284060A
(zh)
|
1997-12-12 |
2001-02-14 |
富士药品工业株式会社 |
新的金属蛋白酶抑制剂
|
|
EP0922702A1
(de)
|
1997-12-13 |
1999-06-16 |
Roche Diagnostics GmbH |
Neue Azulenderivate und diese enthaltende Arzneimittel
|
|
US6335329B1
(en)
|
1997-12-19 |
2002-01-01 |
Amgen Inc. |
Carboxylic acid substituted heterocycles, derivatives thereof and methods of use
|
|
US6107291A
(en)
|
1997-12-19 |
2000-08-22 |
Amgen Inc. |
Azepine or larger medium ring derivatives and methods of use
|
|
DE69830513T2
(de)
|
1997-12-22 |
2006-03-16 |
Bayer Pharmaceuticals Corp., West Haven |
HEMMUNG DER p38 KINASE UNTER VERWENDUNG VON SYMMETRISCHEN UND ASYMMETRISCHEN DIPHENYLHARNSTOFFEN
|
|
WO1999032413A1
(en)
|
1997-12-23 |
1999-07-01 |
Spectran Corporation |
Method of making large scale optical fiber preforms with improved properties
|
|
AU2240299A
(en)
|
1998-01-27 |
1999-08-09 |
American Cyanamid Company |
2,3,4,5-tetrahydro-1h-(1,4)-benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors
|
|
GB9801690D0
(en)
|
1998-01-27 |
1998-03-25 |
Pfizer Ltd |
Therapeutic agents
|
|
US6071903A
(en)
*
|
1998-01-27 |
2000-06-06 |
American Cyanamid Company |
2,3,4,5-tetrahydro-1H-[1,4]-benzodiazepine-3-hydroxyamic acids
|
|
US6100266A
(en)
|
1998-01-30 |
2000-08-08 |
Darwin Discovery Limited |
Hydroxamic and carboxylic acid derivatives
|
|
CN1195735C
(zh)
|
1998-02-04 |
2005-04-06 |
诺瓦提斯公司 |
抑制使基质退化的金属蛋白酶的磺酰氨基衍生物
|
|
DE69910542T2
(de)
|
1998-02-06 |
2004-06-09 |
Darwin Discovery Ltd., Slough |
Hydroxamsäure- und carbonsäurederivative
|
|
HUP0101837A3
(en)
|
1998-02-19 |
2001-11-28 |
American Cyanamid Co Madison |
N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
|
|
PA8469401A1
(es)
|
1998-04-10 |
2000-05-24 |
Pfizer Prod Inc |
Derivados biciclicos del acido hidroxamico
|
|
ES2220004T3
(es)
|
1998-04-10 |
2004-12-01 |
Pfizer Products Inc. |
Derivados del acido ciclobutil-ariloxiarilsulfonilaminohidroxamico.
|
|
AU3982599A
(en)
|
1998-05-14 |
1999-11-29 |
Du Pont Pharmaceuticals Company |
Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
|
|
EP1077974A1
(en)
|
1998-05-14 |
2001-02-28 |
Du Pont Pharmaceuticals Company |
Substituted aryl hydroxamic acids as metalloproteinase inhibitors
|
|
US6288063B1
(en)
|
1998-05-27 |
2001-09-11 |
Bayer Corporation |
Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors
|
|
EP1087937A1
(en)
|
1998-06-17 |
2001-04-04 |
Du Pont Pharmaceuticals Company |
Cyclic hydroxamic acids as metalloproteinase inhibitors
|
|
FR2780402B1
(fr)
|
1998-06-30 |
2001-04-27 |
Adir |
Nouveaux composes acides carboxyliques et hydroxamiques inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
DE19831980A1
(de)
|
1998-07-16 |
2000-01-20 |
Hoechst Marion Roussel De Gmbh |
Sulfonylaminophosphin- und phosphonsäurederivate
|
|
WO2000006560A1
(en)
|
1998-07-30 |
2000-02-10 |
Warner-Lambert Company |
Tricyclic heteroaromatics and their derivatives as inhibitors of matrix metalloproteinases
|
|
IL140746A0
(en)
|
1998-07-30 |
2002-02-10 |
Warner Lambert Co |
Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
|
|
UA59453C2
(uk)
|
1998-08-12 |
2003-09-15 |
Пфайзер Продактс Інк. |
Похідні гідроксипіпеколат гідроксамової кислоти як інгібітори матричних металопротеїназ
|
|
JP2002523454A
(ja)
|
1998-08-26 |
2002-07-30 |
グラクソ グループ リミテッド |
治療剤としてのホルムアミド類
|
|
AU5688999A
(en)
|
1998-08-26 |
2000-03-21 |
Glaxo Group Limited |
Formamide compounds as therapeutic agents
|
|
WO2000012082A1
(en)
|
1998-08-26 |
2000-03-09 |
Glaxo Group Limited |
Formamide compounds as therapeutic agents
|
|
JP2002523492A
(ja)
|
1998-08-29 |
2002-07-30 |
ブリティッシュ バイオテック ファーマシューティカルズ リミテッド |
タンパク質分解酵素阻害剤としてのヒドロキサム酸誘導体
|
|
GB9919776D0
(en)
|
1998-08-31 |
1999-10-27 |
Zeneca Ltd |
Compoujnds
|
|
BR9913562A
(pt)
|
1998-09-11 |
2001-05-22 |
Ajinomoto Kk |
Derivados de benzeno, inibidor de ativação de ap-1 e nf-capa b, inibidor de produção de citoquina inflamatória, inibidor de produção de metaloprotease matricial ou inibidor de aparecimento de fator de adesão de célula inflamatório, e, agente antiinflamatório, anti-reumático, imunossupressor, inibidor de metástase cancerosa, remédio para arterioesclerose e agente antiviral
|
|
US6451792B1
(en)
|
1998-09-22 |
2002-09-17 |
Ishihara Sangyo Kaisha Ltd. |
Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
|
|
EP1123281B1
(en)
|
1998-10-23 |
2003-10-22 |
Dow AgroSciences LLC |
3-(substituted phenyl)-5-(substituted cyclopropyl)-1,2,4-triazole compounds
|
|
ATE260255T1
(de)
*
|
1998-11-05 |
2004-03-15 |
Pfizer Prod Inc |
5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
|
|
GB9826153D0
(en)
|
1998-11-27 |
1999-01-20 |
Hoffmann La Roche |
Hydrazine derivatives
|
|
TR200101644T2
(tr)
|
1998-12-11 |
2001-11-21 |
F.Hoffmann-La Roche Ag |
TNF-ALFA önleyicileri olarak siklik hidrazin türevleri.
|
|
WO2000037433A1
(en)
|
1998-12-18 |
2000-06-29 |
Abbott Laboratories |
Inhibitors of matrix metalloproteinases
|
|
US6372747B1
(en)
*
|
1998-12-18 |
2002-04-16 |
Schering Corporation |
Farnesyl protein transferase inhibitors
|
|
JP2002536964A
(ja)
|
1998-12-22 |
2002-11-05 |
サブサイダリー ナンバースリー インコーポレイテッド |
ヒト免疫不全ウイルスに対する遺伝子抑制エレメント
|
|
CA2358939A1
(en)
|
1998-12-31 |
2000-07-13 |
Joseph P. Burkhart |
3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase
|
|
WO2000040564A1
(en)
|
1998-12-31 |
2000-07-13 |
Aventis Pharmaceuticals Inc. |
N-carboxymethyl substituted benzolactams as inhibitors of matrix metalloproteinase
|
|
EP1140895B1
(en)
|
1999-01-07 |
2004-03-24 |
Fujisawa Pharmaceutical Co., Ltd. |
Thiopyran compounds as inhibitors of mmp
|
|
WO2000042436A1
(en)
|
1999-01-14 |
2000-07-20 |
Ca*Tx, Inc. |
Immunoassays to detect diseases or disease susceptibility traits
|
|
FR2788525B1
(fr)
|
1999-01-19 |
2002-11-29 |
Commissariat Energie Atomique |
Pseudo-peptides phosphiniques, utilisables comme inhibiteurs des metalloproteases a zinc matricielles
|
|
US6294539B1
(en)
*
|
1999-01-19 |
2001-09-25 |
Advanced Syntech, Llc |
Heterocyclic hydroxamic acid derivatives as MMP inhibitors
|
|
AR022424A1
(es)
|
1999-01-27 |
2002-09-04 |
American Cyanamid Co |
Compuestos derivados de acidos ortosulfonamido acetilenico e hidroxamico biciclico heteroarilo amido de acido fosfinico como inhibidores tace, composicionfarmaceutica que los comprende y el uso de los mismos para la manufactura de un medicamento
|
|
AR022423A1
(es)
|
1999-01-27 |
2002-09-04 |
American Cyanamid Co |
Compuestos derivados de acidos 2,3,4,5-tetrahidro-1h-[1,4]benzodiazepina-3-hidroxamicos, composicion farmaceutica que los comprenden, y el uso de losmismos para la manufactura de un medicamento
|
|
BR0007784A
(pt)
|
1999-01-27 |
2002-02-05 |
American Cyanamid Co |
Composto, método para inibir mudanças patológicas mediadas pela enzima que converte o tnf-alfa (tace) em um mamìfero, composição farmacêutica, e, processo para preparar um composto
|
|
US6326516B1
(en)
*
|
1999-01-27 |
2001-12-04 |
American Cyanamid Company |
Acetylenic β-sulfonamido and phosphinic acid amide hydroxamic acid TACE inhibitors
|
|
IL144347A0
(en)
|
1999-01-27 |
2002-05-23 |
American Cyanamid Co |
Acetylenic sulfonamide thiol tace inhibitors
|
|
AR035311A1
(es)
|
1999-01-27 |
2004-05-12 |
Wyeth Corp |
Derivados de acido hidroxamico que contienen alquinilo, como inhibidores de las metalloproteinasas de matriz y de la tace, composicion farmaceutica y el uso de los mismos para la manufactura de un medicamento
|
|
AR035478A1
(es)
|
1999-01-27 |
2004-06-02 |
Wyeth Corp |
Acido amida-hidroxamico, acido acetilenico, beta-sulfonamido y fosfinico como inhibidores de la tace, uso de los mismos para la manufactura de un medicamento y composicion farmaceutica que los contiene
|
|
AR035313A1
(es)
|
1999-01-27 |
2004-05-12 |
Wyeth Corp |
Inhibidores de tace acetilenicos de acido hidroxamico de sulfonamida a base de alfa-aminoacidos, composiciones farmaceuticas y el uso de los mismos para la manufactura de medicamentos.
|
|
US6277885B1
(en)
*
|
1999-01-27 |
2001-08-21 |
American Cyanamid Company |
Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
|
|
US6225311B1
(en)
*
|
1999-01-27 |
2001-05-01 |
American Cyanamid Company |
Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors
|
|
US6200996B1
(en)
*
|
1999-01-27 |
2001-03-13 |
American Cyanamid Company |
Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
|
|
US6313123B1
(en)
*
|
1999-01-27 |
2001-11-06 |
American Cyanamid Company |
Acetylenic sulfonamide thiol tace inhibitors
|
|
AR022422A1
(es)
|
1999-01-27 |
2002-09-04 |
American Cyanamid Co |
Inhibidores de tace acetilenicos de acido hidroxamico de heteroarilfulfonamida y amida del acido fosfinico
|
|
AU2320500A
(en)
|
1999-02-02 |
2000-08-25 |
Shionogi & Co., Ltd. |
Sulfonamide derivatives having cyclic structures
|
|
JP2002536373A
(ja)
|
1999-02-08 |
2002-10-29 |
ジー・ディー・サール・アンド・カンパニー |
スルファメトヒドロキサム酸メタロプロテアーゼ阻害剤
|
|
US6177077B1
(en)
*
|
1999-02-24 |
2001-01-23 |
Edward L. Tobinick |
TNT inhibitors for the treatment of neurological disorders
|
|
WO2000050391A1
(en)
|
1999-02-26 |
2000-08-31 |
Merck & Co., Inc. |
Novel sulfonamide compounds and uses thereof
|
|
WO2000058280A1
(en)
|
1999-03-26 |
2000-10-05 |
Shionogi & Co., Ltd. |
Carbocyclic sulfonamide derivatives
|
|
AU3196100A
(en)
|
1999-03-26 |
2000-10-16 |
Shionogi & Co., Ltd. |
Heterocyclic sulfonamide derivatives
|
|
WO2000058278A1
(fr)
|
1999-03-26 |
2000-10-05 |
Shionogi & Co., Ltd. |
Derives d'acides amines $g(b)
|
|
EP1041072B1
(en)
|
1999-03-31 |
2003-07-16 |
Pfizer Products Inc. |
Dioxocyclopentyl hydroxamic acids
|
|
CA2366264A1
(en)
*
|
1999-04-02 |
2000-10-12 |
Bristol-Myers Squibb Company |
Novel amide derivatives as inhibitors of matrix metalloproteinases, tnf-.alpha., and aggrecanase
|
|
WO2000063194A1
(en)
|
1999-04-19 |
2000-10-26 |
Shionogi & Co., Ltd. |
Sulfonamide derivatives having oxadiazole rings
|
|
AUPP982399A0
(en)
|
1999-04-19 |
1999-05-13 |
Fujisawa Pharmaceutical Co., Ltd. |
Mmp inhibitor
|
|
AU4249700A
(en)
|
1999-04-19 |
2000-11-02 |
Sumitomo Pharmaceuticals Company, Limited |
Hydroxamic acid derivative
|
|
GB9911071D0
(en)
|
1999-05-12 |
1999-07-14 |
Darwin Discovery Ltd |
Hydroxamic and carboxylic acid derivatives
|
|
CA2373439A1
(en)
|
1999-05-17 |
2000-11-23 |
Tetsunori Fujisawa |
Novel hydroxamic acid derivatives
|
|
EP1081137A1
(en)
|
1999-08-12 |
2001-03-07 |
Pfizer Products Inc. |
Selective inhibitors of aggrecanase in osteoarthritis treatment
|
|
GB9922825D0
(en)
|
1999-09-25 |
1999-11-24 |
Smithkline Beecham Biolog |
Medical use
|
|
US6632667B1
(en)
|
1999-10-28 |
2003-10-14 |
Isis Pharmaceuticals, Inc. |
Modulation of L-selectin shedding via inhibition of tumor necrosis factor-α converting enzyme (TACE)
|
|
GB0004153D0
(en)
|
2000-02-23 |
2000-04-12 |
Astrazeneca Uk Ltd |
Novel use
|
|
AU4007401A
(en)
|
2000-03-06 |
2001-09-17 |
Bioseek Inc |
Function homology screening
|
|
CN1481377A
(zh)
|
2000-03-17 |
2004-03-10 |
����˹�ж�-����˹˹����ҩƷ��˾ |
作为基质金属蛋白酶和TNF-α的抑制剂的环β-氨基酸衍生物
|
|
BR0109469A
(pt)
|
2000-03-17 |
2003-04-29 |
Bristol Myers Squibb Co |
Compostos derivados de b-aminoácidos, composição farmacêutica, método para o tratamento ou prevenção de disfunções inflamatórias, método para o tratamento de condições ou doenças mediadas por mmps, tnf, aggrecanase ou uma combinação destes em mamìferos e uso do composto
|
|
JP2003533521A
(ja)
|
2000-05-15 |
2003-11-11 |
ダーウィン・ディスカバリー・リミテッド |
ヒドロキサム酸誘導体
|
|
US6620823B2
(en)
|
2000-07-11 |
2003-09-16 |
Bristol-Myers Squibb Pharme Company |
Lactam metalloprotease inhibitors
|
|
US20040029928A1
(en)
|
2000-08-31 |
2004-02-12 |
Terukage Hirata |
Novel propenohydroxamic acid derivatives
|
|
CA2447475A1
(en)
|
2001-05-25 |
2002-12-05 |
Chu-Biao Xue |
Hydantion derivatives as inhibitors of matrix metalloproteinases
|
|
SE519050C2
(sv)
|
2001-05-28 |
2003-01-07 |
Fazer Ab Oy Karl |
Påfyllnadsanordning för varor
|
|
WO2003016248A2
(en)
|
2001-08-17 |
2003-02-27 |
Bristol-Myers Squibb Company Patent Department |
Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace)
|
|
US6740649B2
(en)
|
2001-09-17 |
2004-05-25 |
Bristol-Myers Squibb Company |
Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- α converting enzyme (TACE)
|